Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis-Reference-Cited by-同舟云学术

Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis

Published:2017-02 Issue:2 Volume:137 Page:359-366
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Liu Yuangang,Wang Zhiping,De La Torre Rachel,Barling Ashley,Tsujikawa Takahiro,Hornick Noah,Hanifin Jon,Simpson Eric,Wang Yun,Swanzey Emily,Wortham Aaron,Ding Hao,Coussens Lisa M.,Kulesz-Martin Molly

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference54 articles.

1. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype;Ahmad-Nejad;J Allergy Clin Immunol,2004

2. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB;Albor;J Biol Chem,2006

3. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo;Aronica;J Immunol,1999

4. Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects;Beck;J Immunol,1997

5. Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice;Brandt;J Immunol,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Genetic Landscape of Vitiligo in the Pura Raza Español Horse: A Genomic Perspective;Animals;2024-08-21

2. Multifaceted role of TRIM21 in inflammation;Biologia Futura;2024-05-08

3. Identification of inflammation-related biomarkers in keloids;Frontiers in Immunology;2024-02-20

4. Skin barrier immunology from early life to adulthood;Mucosal Immunology;2023-04

5. Elevated IgE from attenuated CARD11 signaling: lessons from atopic mice and humans;Current Opinion in Immunology;2022-12